SSKN Stock Forecast 2025-2026
Distance to SSKN Price Targets
SSKN Price Momentum
10 Quality Stocks Worth Considering Now
Researching Strata Skin (SSKN) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on SSKN and similar high-potential opportunities.
Latest SSKN Stock Price Targets & Analyst Predictions
Based on our analysis of 4 Wall Street analysts, SSKN has a bullish consensus with a median price target of $11.00 (ranging from $6.00 to $16.00). Currently trading at $2.55, the median forecast implies a 331.4% upside. This outlook is supported by 2 Buy, 0 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Anthony Vendetti at Maxim Group, suggesting a 135.3% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
SSKN Analyst Ratings
SSKN Price Target Range
Latest SSKN Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for SSKN.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Feb 27, 2025 | Maxim Group | Anthony Vendetti | Buy | Initiates | $6.00 |
| May 16, 2023 | CG Capital | Rich Cockrell | Outperform | Reiterates | $4.00 |
| Nov 3, 2020 | HC Wainwright & Co. | Joseph Pantginis | Buy | Upgrade | $3.00 |
| Mar 17, 2020 | HC Wainwright & Co. | Neutral | Downgrade | $0.00 | |
| Dec 9, 2019 | Ladenburg Thalmann | Buy | Initiates | $0.00 | |
| Nov 21, 2019 | Oppenheimer | Outperform | Initiates | $0.00 | |
| Dec 10, 2018 | Northland Capital Markets | Outperform | Initiates | $0.00 | |
| Dec 10, 2018 | Northland Securities | Outperform | Initiates | $0.00 |
Strata Skin Sciences Inc. (SSKN) Competitors
The following stocks are similar to Strata Skin based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Strata Skin Sciences Inc. (SSKN) Financial Data
Strata Skin Sciences Inc. has a market capitalization of $10.72M with a P/E ratio of -0.8x. The company generates $32.68M in trailing twelve-month revenue with a -28.7% profit margin.
Revenue growth is -0.6% quarter-over-quarter, while maintaining an operating margin of -18.8% and return on equity of -73.5%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Strata Skin Sciences Inc. (SSKN) Business Model
About Strata Skin Sciences Inc.
Develops and commercializes dermatological treatment technologies.
The company generates revenue by selling its innovative dermatological treatment products, particularly the XTRAC laser system, which is designed for non-invasive treatment of skin conditions like psoriasis and vitiligo. Strata operates primarily in the medical technology sector, serving dermatology clinics and medical practices that require effective solutions for chronic skin conditions.
Strata Skin Sciences is positioned in a growing market that demands advanced dermatological solutions, highlighting its importance in improving patient care. The company focuses on continuous innovation and expanding its treatment options, which reflects its commitment to enhancing the quality of life for individuals with skin disorders.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
99
CEO
Dr. Dolev Rafaeli Ph.D.
Country
United States
IPO Year
2005
Website
www.strataskinsciences.comStrata Skin Sciences Inc. (SSKN) Latest News & Analysis
STRATA Skin Sciences, Inc. (NASDAQ: SSKN) will report its Q4 and year-end 2024 financial results on March 27, 2025, after market close.
STRATA's upcoming financial results could significantly impact its stock price and investor sentiment, reflecting the company's performance and future growth potential in the dermatology sector.
STRATA Skin Sciences announced a study validating its Excimer Laser technology's superiority in treating skin conditions like Vitiligo and Psoriasis, showing better clinical outcomes than traditional UVB sources.
The study reinforces STRATA's competitive edge in dermatological treatment technology, potentially boosting market position and investor confidence in future growth and profitability.
Strata Skin Sciences (SSKN) is highlighted as a strong momentum stock trading at reasonable prices, passing the 'Fast-Paced Momentum at a Bargain' screening for potential investors.
Strata Skin Sciences shows strong momentum and is priced attractively, suggesting potential for growth and value, making it appealing for investors seeking opportunities.
STRATA Skin Sciences to Participate in the Benchmark Company 13th Annual Discovery Investor Conference
3 months agoSTRATA Skin Sciences (NASDAQ: SSKN) CEO Dr. Dolev Rafaeli will present at the Benchmark Company 13th Annual Discovery Investor Conference on December 11, 2024, in New York City.
Dr. Rafaeli's participation in a major investor conference may enhance STRATA's visibility and credibility, potentially attracting new investments and influencing stock performance.
STRATA Skin Sciences, Inc. (SSKN) held its Q3 2024 earnings call, discussing financial performance and company developments. Further details are available in the full transcript.
The Q3 2024 earnings call provides insights into STRATA Skin Sciences' financial performance, growth strategies, and market positioning, influencing investor sentiment and stock valuation.
STRATA Skin Sciences Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
4 months agoSTRATA Skin Sciences (NASDAQ: SSKN) announced its financial results for Q3 2024, ending September 30, and provided a corporate update.
STRATA's quarterly financial results and corporate update can impact stock performance, reflecting revenue growth potential and operational progress, which are critical for investor confidence.
Frequently Asked Questions About SSKN Stock
What is Strata Skin Sciences Inc.'s (SSKN) stock forecast for 2025?
Based on our analysis of 4 Wall Street analysts, Strata Skin Sciences Inc. (SSKN) has a median price target of $11.00. The highest price target is $16.00 and the lowest is $6.00.
Is SSKN stock a good investment in 2025?
According to current analyst ratings, SSKN has 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $2.55. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for SSKN stock?
Wall Street analysts predict SSKN stock could reach $11.00 in the next 12 months. This represents a 331.4% increase from the current price of $2.55. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Strata Skin Sciences Inc.'s business model?
The company generates revenue by selling its innovative dermatological treatment products, particularly the XTRAC laser system, which is designed for non-invasive treatment of skin conditions like psoriasis and vitiligo. Strata operates primarily in the medical technology sector, serving dermatology clinics and medical practices that require effective solutions for chronic skin conditions.
What is the highest forecasted price for SSKN Strata Skin Sciences Inc.?
The highest price target for SSKN is $16.00 from at , which represents a 527.5% increase from the current price of $2.55.
What is the lowest forecasted price for SSKN Strata Skin Sciences Inc.?
The lowest price target for SSKN is $6.00 from Anthony Vendetti at Maxim Group, which represents a 135.3% increase from the current price of $2.55.
What is the overall SSKN consensus from analysts for Strata Skin Sciences Inc.?
The overall analyst consensus for SSKN is bullish. Out of 4 Wall Street analysts, 2 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $11.00.
How accurate are SSKN stock price projections?
Stock price projections, including those for Strata Skin Sciences Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
